Gelteq Limited - (GELS) closed at $0.45 on October 26, 2026, up 4.0% from the previous close, on volume of 170,311 shares (30-day average 1,181,689).
Data as of October 26, 2026.
No press releases found.
Gelteq’s Palatability Trials with Kemin Highlight Major Breakthrough in Animal Health Applications
Market Chameleon (Mon, 15-Jun 6:29 AM ET)
Gelteq’s Gel Platform Boosts Drug Absorption by up to 45%—Expanding Prospects Beyond Antihistamines
Market Chameleon (Mon, 24-Nov 4:54 AM ET)
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
Gelteq Limited - trades on the NASDAQ stock market under the symbol GELS.
As of October 26, 2026, GELS stock price climbed to $0.45 with 170,311 million shares trading.
GELS has a beta of 1.50, meaning it tends to be more sensitive to market movements. GELS has a correlation of 0.02 to the broad based SPY ETF.
GELS has a market cap of $4.79 million. This is considered a Sub-Micro Cap stock.
GELS has underperformed the market in the last year with a price return of -67.8% while the SPY ETF gained +15.1%. GELS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -39.8% and -14.2%, respectively, while the SPY returned +3.9% and -1.7%, respectively.
GELS support price is $.41 and resistance is $.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GELS shares will trade within this expected range on the day.
